John Fromson
Direktor/Vorstandsmitglied bei NeuroTargets Ltd.
Aktive Positionen von John Fromson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von John Fromson
Ehemalige bekannte Positionen von John Fromson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Generis Capital Partners SAS
 Generis Capital Partners SAS Investment ManagersFinance Generis Capital Partners SAS (GCP) is an independent venture capital and private equity firm founded in 2008 by Thibaut de Roux. The firm is headquartered in Paris, France. | Private Equity Investor | 01.04.2010 | 31.12.2010 |
Ultrafine Ltd. (Gillingham)
 Ultrafine Ltd. (Gillingham) Miscellaneous Commercial ServicesCommercial Services Ultrafine Ltd. researches and develops chemical compounds. The company was founded on March 12, 2004 and is headquartered in Gillingham, the United Kingdom. | Vorsitzender | - | - |
| Vanguard Medica Plc | Corporate Officer/Principal | - | - |
Innovata Ltd.
 Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigtes Königreich | 5 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 2 |
| Chairman | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Health Technology |
Innovata Ltd.
Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Ultrafine Ltd. (Gillingham)
Ultrafine Ltd. (Gillingham) Miscellaneous Commercial ServicesCommercial Services Ultrafine Ltd. researches and develops chemical compounds. The company was founded on March 12, 2004 and is headquartered in Gillingham, the United Kingdom. | Commercial Services |
| Vanguard Medica Plc | Commercial Services |
Generis Capital Partners SAS
Generis Capital Partners SAS Investment ManagersFinance Generis Capital Partners SAS (GCP) is an independent venture capital and private equity firm founded in 2008 by Thibaut de Roux. The firm is headquartered in Paris, France. | Finance |
- Börse
- Insiders
- John Fromson
- Erfahrung
